🔗 Share this article

An underground market for unapproved slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Experimental Treatment Gaining Popularity Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are encouraged to contact these profiles directly for source information, while also receiving discount codes.

Active Trade on Social Networks

Separately, a flourishing trade exists on Telegram, where groups with numerous of members share “before and after” images, administration instructions and assertions of next-day British shipping. Sellers promote the substance there before redirecting customers to WhatsApp for transactions.

Understanding Retatrutide

Retatrutide is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Professionals Voice Concerns

Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unapproved drug in the United Kingdom is worrisome and could result in individuals administering substances of unknown origin.

Several professionals said the popularity for retatrutide could be linked to the rising cost of approved slimming products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved medication that must not be marketed or supplied for human use under the British medical regulations.

Several content creators try to sidestep the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach pharmaceutical, marketing, and customer regulations, potentially leading to fines, prosecution or imprisonment.

Service Reaction and Content Removal

According to TikTok, the platform has removed problematic content and prohibited associated hashtags and search suggestions. The organization said it was committed to keeping the service safe and allocating resources in strengthening compliance measures.

Digital Trading Activities

Investigations also discovered groups with up to 9,000 members marketing the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly brings up channels with numerous of users, filled with photos of weight loss, glowing reviews and detailed instructions for mixing or administering at home.

After minutes of joining one group, a vendor shared contact information, where most transactions occur. The vendor sent an instruction manual and guaranteed delivery within two days. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about weight, medical conditions or previous experience.

Product Details and Costs

Inside these communities, messages show dark colored packages with Royal Mail stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with purified liquid, or pre-filled injectors usually sold at 160 pounds for 20 milligrams. When asked how long a pen should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.

Service Oversight and Safety Actions

A representative for the messaging service stated it actively monitored dangerous content on its platform including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting substances they cannot confirm. Although the science behind this drug is valid, these online products may not include what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in interest to recent price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, individuals are using social media. But fake injections are highly dangerous. You cannot know what’s inside or whether the environment they were made in was clean,” she said.

Her team has previously seen patients injured by self-injection from unconfirmed suppliers. “We recognize the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” said Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency globally. “Therefore at this time no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly investigational substance not yet approved … may expose users to possibly significant medical dangers”.